EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Peptides From Amphibian Skin as Potential Therapeutics

Bisma, Muhammad Owais Khan, Dr. Usman Siddiq, Afshan Pervaiz, Syed Hasnain Ul Haque, Mehwish Imtiaz

Journal of Health, Wellness and Community Research · 14.05.2026 · 4 (9) · 1-11

DOI: 10.61919/rbej1t38 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Health, Wellness and Community Research, online erschienen am 14.05.2026. Verfasst von Bisma und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multidrug-resistant bacterial infections are a growing challenge in tertiary-care hospitals, particularly where antimicrobial pressure is high and treatment options are limited. Amphibian skin secretions contain antimicrobial peptides that may provide novel leads for anti-infective development.

Objective

This study aimed to isolate peptide-containing fractions from amphibian skin secretions and evaluate their in vitro antibacterial, antibiofilm, safety, and stability profiles against multidrug-resistant clinical isolates.

Methods

An experimental laboratory-based study was conducted using 87 non-duplicate multidrug-resistant isolates, including MRSA, ESBL-producing Escherichia coli, ESBL-producing Klebsiella pneumoniae, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii. Amphibian skin secretions were processed into crude extract and purified by RP-HPLC to obtain two active fractions, AMP-1 and AMP-2. Antibacterial activity was assessed using MIC and MBC testing, time–kill kinetics, biofilm inhibition and disruption assays, hemolysis testing, mammalian-cell viability screening, and short-term serum stability assessment.

Results

AMP-1 showed the strongest antibacterial profile, with median MICs of 4 µg/mL against MRSA, 8 µg/mL against ESBL-producing E. coli, and 16 µg/mL against carbapenem-resistant P. aeruginosa. MBCs were generally one dilution above MIC values. AMP-1 produced concentration-dependent killing against MRSA, inhibited biofilm formation more effectively than it disrupted mature biofilm, and showed lower hemolysis than AMP-2 at matched concentrations. AMP-1 retained 76% activity after 4 hours in 25% serum, compared with 68% for AMP-2.

Conclusion

Amphibian-derived AMP fractions, particularly AMP-1, demonstrated promising in vitro activity and preliminary selectivity against MDR pathogens, supporting further peptide characterization, optimization, formulation development, and preclinical validation

Zitieren

APA

Bisma, Khan, M. O., Siddiq, D. U., Pervaiz, A., Haque, S. H. U., & Imtiaz, M. (2026). Antimicrobial Peptides From Amphibian Skin as Potential Therapeutics. Journal of Health, Wellness and Community Research, 4(9), 1-11. https://doi.org/10.61919/rbej1t38

Vancouver

Bisma, Khan MO, Siddiq DU, Pervaiz A, Haque SHU, Imtiaz M. Antimicrobial Peptides From Amphibian Skin as Potential Therapeutics. Journal of Health, Wellness and Community Research. 2026;4(9):1-11. doi:10.61919/rbej1t38

BibTeX
@article{Bisma2026,
  author = {Bisma and Khan, Muhammad Owais and Siddiq, Dr. Usman and Pervaiz, Afshan and Haque, Syed Hasnain Ul and Imtiaz, Mehwish},
  title = {Antimicrobial Peptides From Amphibian Skin as Potential Therapeutics},
  journal = {Journal of Health, Wellness and Community Research},
  year = {2026},
  volume = {4},
  number = {9},
  pages = {1--11},
  doi = {10.61919/rbej1t38}
}
Kostenlos starten →